| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.3B | $6.6B | $7.0B | $7.0B | $6.3B | $5.8B | $1.4B | $1.4B |
| Cost of Revenue | $0.1B | $1.8B | $1.9B | $2.0B | $0.4B | $0.4B | $0.5B | $0.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.7B | $0.8B | $0.8B | $0.7B | $0.7B | $0.6B | $0.6B |
| Operating Income | $2.1B | $-2.9B | $2.4B | $2.4B | $2.0B | $1.9B | $0.4B | $0.4B |
| Net Income | $0.4B | $-3.9B | $1.5B | $1.7B | $1.1B | $1.1B | $0.2B | $0.2B |
| EPS (Basic) | $1.02 | $-8.98 | $3.46 | $3.87 | $2.54 | $2.36 | $0.43 | $0.45 |
| EPS (Diluted) | $1.01 | $-8.98 | $3.46 | $3.86 | $2.53 | $2.35 | $0.43 | $0.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.5B | $32.7B | $38.5B | $38.9B | $39.0B | $38.8B | $38.5B | $32.8B |
| Current Assets | $1.1B | $1.1B | $1.0B | $1.2B | $1.3B | $1.1B | $1.2B | $1.2B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.2B | $0.3B | $0.2B | $0.2B | $0.3B |
| Total Liabilities | $33.2B | $32.9B | $32.1B | $31.5B | $30.8B | $29.3B | $28.0B | $20.8B |
| Current Liabilities | $4.5B | $2.2B | $2.6B | $2.7B | $2.0B | $2.0B | $1.9B | $1.4B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.1B | $2.9B | $3.1B | $2.9B | $2.8B | $3.1B | $2.7B | $2.5B |
| Investing Cash Flow | $-1.2B | $-1.2B | $-1.5B | $-1.4B | $-1.3B | $-1.7B | $-2.1B | $-1.8B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.9B | $-1.7B | $-1.7B | $-1.7B | $-1.3B | $-1.3B | $-0.7B | $-0.7B |